Trade Summary

5 days ago, QVT Financial LP, serving as Director by Deputization at Roivant Sciences Ltd. (ROIV), sold 1,438,163 shares at $34.32 per share, for a total transaction value of $49,354,075.76. Following this transaction, QVT Financial LP now holds 13,689,166 shares of ROIV.

This sale represents a 9.51% decrease in QVT Financial LP's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 26, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 30, 2026 at 7:59 PM ET, 4 days after the trade was made.

Roivant Sciences Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.